192 related articles for article (PubMed ID: 31324239)
1. A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression.
Hu Y; Wu Q; Gao J; Zhang Y; Wang Y
BMC Urol; 2019 Jul; 19(1):67. PubMed ID: 31324239
[TBL] [Abstract][Full Text] [Related]
2. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
3. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
Benko G; Spajić B; Krušlin B; Tomas D
Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic rather than prognostic markers-relationship between EpCAM overexpression and lung cancer: a meta-analysis.
Zhu T; Peng X; Cheng Z; Xing D; Zhang M
Ann Palliat Med; 2021 Apr; 10(4):4025-4036. PubMed ID: 33832309
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
Cao Z; Wei L; Zhu W; Yao X
Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
[TBL] [Abstract][Full Text] [Related]
7. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
9. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
10. [Expression of the epithelial cell adhesion molecule in prostate cancer and its clinical significance].
Li ZL; Jin RS
Zhonghua Nan Ke Xue; 2015 Apr; 21(4):320-4. PubMed ID: 26027098
[TBL] [Abstract][Full Text] [Related]
11. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
12. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
Chen Q; Zhong T
Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis.
Zeng L; Deng X; Zhong J; Yuan L; Tao X; Zhang S; Zeng Y; He G; Tan P; Tao Y
BMC Cancer; 2019 Aug; 19(1):831. PubMed ID: 31443698
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis.
Ding P; Chen P; Ouyang J; Li Q; Li S
Front Oncol; 2023; 13():1242231. PubMed ID: 37664060
[TBL] [Abstract][Full Text] [Related]
15. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.
Sen S; Carnelio S
Histopathology; 2016 May; 68(6):897-904. PubMed ID: 26401964
[TBL] [Abstract][Full Text] [Related]
18. EpCAM and COX‑2 expression are positively correlated in human breast cancer.
Gao S; Sun Y; Liu X; Zhang D; Yang X
Mol Med Rep; 2017 Jun; 15(6):3755-3760. PubMed ID: 28393249
[TBL] [Abstract][Full Text] [Related]
19. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
Zhang L; Guo F; Gao X; Wu Y
Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
[TBL] [Abstract][Full Text] [Related]
20. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
